Clinical trial
Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing…
NCT00036335 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00036335 |
|---|---|
| Title | Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain |
| Official title | Duloxetine Hydrochloride (LY248686) Protocol F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depression, Pain |
| Intervention type | Drug |
| Interventions | Duloxetine Hydrochloride |
| Enrollment | 286 |
| Start date | Mar 1, 2002 |
| Completion | Jan 1, 2003 |
| First posted | May 10, 2002 |
| Last update posted | Jul 19, 2006 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: